Gene · 51547
Papers2,721
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,721
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ningxintong and its active component calycosin stabilize vulnerable atherosclerotic plaques by targeting SIRT7 and inhibiting pyroptosis. | Phytomedicine | 2026 | 42815265 | PubTator, text mining | PubMed |
| Computational design of siRNAs targeting SIRT7 in gynaecological cancers with cell-penetrating peptide-based delivery assessment. | Comput Biol Chem | 2026 | 42710143 | PubTator, text mining | PubMed |
| Experimental approaches for investigating sirtuin-mediated mitochondrial function, cellular metabolism, and epigenetic regulation. | Methods Enzymol | 2026 | 42692759 | PubTator, text mining | PubMed |
| Comparative transcriptomics analysis of histone deacetylases, transcription factors, and ion channel genes in human iPSC-cardiomyocytes vs. the adult human heart. | J Precis Med (Amst) | 2026 | 42644057 | PubTator, text mining | PubMed |
| SIRT2 deacylase modulators control B cell metabolic reprogramming in EBV infection and mitogenic activation. | Proc Natl Acad Sci U S A | 2026 | 42636358 | PubTator, text mining | PubMed |
| Deciphering the role of sirtuins in cancer immunoregulation through molecular cross-talk and docking-based interaction. | Mol Biol Rep | 2026 | 42627540 | PubTator, text mining | PubMed |
| Correction to "Inhibition of SIRT7 Overcomes Radioresistance in Pancreatic Neuroendocrine Tumors by Reactivating MEN1 Expression". | Adv Sci (Weinh) | 2026 | 42615387 | PubTator, text mining | PubMed |
| Protective mechanisms of Sirtuin Family in myocardial ischemia-reperfusion injury and translational therapeutic perspectives. | Mol Biol Rep | 2026 | 42584557 | PubTator, text mining | PubMed |
| Ferroptosis in vitiligo and melanoma: Opposing susceptibilities, shared mechanisms, and therapeutic targets. | Exp Cell Res | 2026 | 42567394 | PubTator, text mining | PubMed |
| Decoding context-dependent sirtuin pharmacology in cancer: Metabolic-epigenetic switches and precision therapeutic targeting. | Crit Rev Oncol Hematol | 2026 | 42543141 | PubTator, text mining | PubMed |
| NMN alleviates oxidative stress damage in alopecia areata by activating SIRT7 and promoting glutamine metabolism. | Biochim Biophys Acta Gene Regul Mech | 2026 | 42508531 | PubTator, text mining | PubMed |
| [Sirtuins as geroprotectors and epigenetic regulators of cell cycle.] | Adv Gerontol | 2026 | 42502934 | PubTator, text mining | PubMed |
| LncRNA RP11-708J19.2 promotes colorectal cancer progression by binding to SIRT7 via regulating H3K18ac. | Eur J Histochem | 2026 | 42489630 | PubTator, text mining | PubMed |
| [Retracted] Sirtuin 7 promotes glioma proliferation and invasion through activation of the ERK/STAT3 signaling pathway. | Oncol Lett | 2026 | 42488709 | PubTator, text mining | PubMed |
| SIRT Family: Biological Functions and Therapeutic Targets. | MedComm (2020) | 2026 | 42488706 | PubTator, text mining | PubMed |
| Succinylation related gene signature enables risk stratification and prognostic modeling in breast cancer patients. | Amino Acids | 2026 | 42467271 | PubTator, text mining | PubMed |
| Targeting Sirtuin Signaling in Parkinson's Disease and Neurodegeneration: Molecular Insights and Translational Potential. | Mol Neurobiol | 2026 | 42467143 | PubTator, text mining | PubMed |
| Differential NAD + availability may drive asymmetric SIRT7 activity in tumor and immune cells. | Mol Biol Rep | 2026 | 42467120 | PubTator, text mining | PubMed |
| "Lights, camera, (ac)tion!": Damage-induced PCBP1 deacetylation releases PARP1 to engage DNA double-strand breaks. | Mol Cell | 2026 | 42462698 | PubTator, text mining | PubMed |
| SIRT5/7 desuccinylation in cancer: linking metabolism, immunity, and drug resistance. | Biochem Pharmacol | 2026 | 42456824 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51547/papers